SciCombinator

Discover the most talked about and latest scientific content & concepts.

CA Clarke, AJ Canchola, LM Moy, SL Neuhausen, NT Chung, JV Lacey and L Bernstein
Abstract
Regular users of aspirin may have reduced risk of breast cancer. Few studies have addressed whether risk reduction pertains to specific breast cancer subtypes defined jointly by hormone receptor (estrogen and progesterone receptor) and human epidermal growth factor receptor 2 (HER2) expression. This study assessed the prospective risk of breast cancer (overall and by subtype) according to use of aspirin and other non-steroidal anti-inflammatory medications (NSAIDs) in a cohort of female public school professionals in California.
Tweets*
46
Facebook likes*
6
Reddit*
1
News coverage*
108
Blogs*
2
SC clicks
0
Concepts
Immune system, Growth factor, Signal transduction, Estrogen, Epidermal growth factor, Breast cancer, Epidermal growth factor receptor
MeSH headings
-
comments powered by Disqus

* Data courtesy of Altmetric.com